|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features |
| Twitter ~ Facebook |
|
Home
/ Technology News / 2009 / July 2009 / July 2, 2009 |
Marathon training causes heart damage in healthy people
Loneliness linked to high BP in elderly
Increased intake of leafy greens, nuts can cut colon cancer risk in men
When status on the mind, people forgo luxury for green products
Chemical that protects hearts of muscular dystrophy patients discovered
Brain replays control decision-making process, not long-term memories
Scientists to map Chile earthquake site to capture fresh data
A team of scientists are all set to undertake an expedition to explore the rupture site of the 8.8-magnitude Chilean earthquake, which is one of largest quakes in recorded history. ANI
Signature of renaissance artist Raphael found hidden in painting
Reports indicate that art experts have found what they believe is the earliest signature of the master renaissance artist Raphael, hidden within a paintings arabesque decorations. ANI
How global warming can lead to increased violence in human beings
A new research has shown that as the earths average temperature rises, so does human heat in the form of violent tendencies, which links global warming with increased violence in human beings. ANI
Scientists have found that a drug, commonly prescribed to treat high blood pressure, could slow the progression of eye damage in people with type 1 diabetes, a common complication caused by this disease.
London, July 2 : Scientists have found that a drug, commonly prescribed to treat high blood pressure, could slow the progression of eye damage in people with type 1 diabetes, a common complication caused by this disease.
By administering an antihypertensive, University of Minnesota Medical School researcher Michael Mauer, M.D. and colleagues were able to slow progression of diabetic eye damage in more than 65 percent of participants involved in the study.
Three groups of participants were observed over the course of five years. Two groups were administered one of two antihypertensive medications, losartan or enalapril, and the last group, a placebo.
Mauer's study demonstrated that participants who were administered either enalapril or losartan experienced a significant slowing of the progression of diabetic eye injury, by 65 and 70 percent, respectively.
"The secondary results of this study showed that people taking these antihypertensive medications experienced a substantially positive effect in slowing diabetic eye injury," said Mauer.
The study has been published in the July 2nd issue of The New England Journal of Medicine.
ANI
